All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Plays a key role in the switch from latent infection to lytic cycle producing new virions. Acts as a transcription factor, inducing early lytic cycle genes, and as a origin binding protein for genome replication. BZLF1 activates the promoter of another EBV gene (BSLF2+BMLF1).
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-C016Z | Human anti-BZLF1 T cell receptor (SB27), pCDTCR1 | EBV | SB27 | Human | LPEPLPQGQLTAY | HLA-B*3508 | Lentiviral | |
TCR-C017Z | Human anti-BZLF1 T cell receptor (ELS4), pCDTCR1 | EBV | ELS4 | Human | EPLPQGQLTAY | HLA-B*3501 | Lentiviral | |
TCR-C018Z | Human anti-BZLF1 T cell receptor (CA5), pCDTCR1 | EBV | CA5 | Human | LPEPLPQGQLTAY | HLA B*3505 | Lentiviral | |
TCR-C020Z | Human anti-BZLF1 T cell receptor, pCDTCR1 | EBV | Human | PLPQGQLTAY | HLA-B*3501 | Lentiviral | ||
TCR-YC0145 | Human anti-BZLF1 T cell receptor (DY18), pCDTCR1 | EBV | DY18 | Human | EPLPQGQLTAY | HLA-B*35:01 | Lentiviral vector | |
TCR-YC0146 | Human anti-BZLF1 T cell receptor (DY9), pCDTCR1 | EBV | DY9 | Human | EPLPQGQLTAY | HLA-B*35:01 | Lentiviral vector | |
TCR-YC0147 | Human anti-BZLF1 T cell receptor (EL8), pCDTCR1 | EBV | EL8 | Human | EPLPQGQLTAY | HLA-B*35:01 | Lentiviral vector | |
TCR-YC0148 | Human anti-BZLF1 T cell receptor (ELS2), pCDTCR1 | EBV | ELS2 | Human | EPLPQGQLTAY | HLA-B*35:01 | Lentiviral vector | |
TCR-YC0149 | Human anti-BZLF1 T cell receptor (ELS3), pCDTCR1 | EBV | ELS3 | Human | EPLPQGQLTAY | HLA-B*35:01 | Lentiviral vector | |
TCR-YC0151 | Human anti-BZLF1 T cell receptor (GB1), pCDTCR1 | EBV | GB1 | Human | EPLPQGQLTAY | HLA-B*35:01 | Lentiviral vector | |
TCR-YC0152 | Human anti-BZLF1 T cell receptor (GB14), pCDTCR1 | EBV | GB14 | Human | EPLPQGQLTAY | HLA-B*35:01 | Lentiviral vector | |
TCR-YC0153 | Human anti-BZLF1 T cell receptor (MW2), pCDTCR1 | EBV | MW2 | Human | EPLPQGQLTAY | HLA-B*35:01 | Lentiviral vector | |
TCR-ZP114 | Human anti-BZLF1 T cell receptor (ACL-05), pCDTCR1 | EBV | ACL-05 | Human | RAKFKQLL | HLA-B*35:01 | Lentiviral vector | |
TCR-ZP115 | Human anti-BZLF1 T cell receptor (AM23), pCDTCR1 | EBV | AM23 | Human | RAKFKQLL | HLA-B*35:01 | Lentiviral vector | |
TCR-ZP116 | Human anti-BZLF1 T cell receptor (AM30), pCDTCR1 | EBV | AM30 | Human | RAKFKQLL | HLA-B*35:01 | Lentiviral vector | |
TCR-ZP117 | Human anti-BZLF1 T cell receptor (AM42), pCDTCR1 | EBV | AM42 | Human | RAKFKQLL | HLA-B*35:01 | Lentiviral vector | |
TCR-ZP118 | Human anti-BZLF1 T cell receptor (AM7), pCDTCR1 | EBV | AM7 | Human | RAKFKQLL | HLA-B*35:01 | Lentiviral vector | |
TCR-ZP119 | Human anti-BZLF1 T cell receptor (AV), pCDTCR1 | EBV | AV | Human | RAKFKQLL | HLA-B*35:01 | Lentiviral vector | |
TCR-ZP120 | Human anti-BZLF1 T cell receptor (KEL-13), pCDTCR1 | EBV | KEL-13 | Human | RAKFKQLL | HLA-B*35:01 | Lentiviral vector | |
TCR-ZP121 | Human anti-BZLF1 T cell receptor (MCL-05), pCDTCR1 | EBV | MCL-05 | Human | RAKFKQLL | HLA-B*35:01 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION